Now there’s the Harmony Prenatal Test – a simple blood test that assesses the risk of select fetal trisomies as early as 10 weeks gestational age.
Directed DNA analysis is simpler, less costly and more informative compared to random sequencing.
Studied in over 6,000 patients, including >2,000 average-risk women
| Detection Rate | ||
|---|---|---|
| T21 | >99% (231 of 232) |
|
| T18 | >98% (103 of 105) |
|
| T13 | 8 of 10 detected with Harmony | |
| False Positive Rate |
|---|
| <0.1% |
| <0.1% |
| <0.1% |
Directed DNA analysis accurately detects select fetal trisomies in pregnancies of 10 weeks or more.
The non-invasive prenatal testing sector is a growing industry within molecular diagnostics. Ariosa Diagnostics invites you to learn more about our job openings.